No. |
Variant name |
Chromosome position |
Chromatin state |
Related regulatory elements |
Target genes |
Extended variants |
Associated traits |
1 |
rs2333912 |
chr2:112069814-112069815 |
Weak transcription Enhancers Genic enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
2 |
rs112083854 |
chr2:112069825-112069826 |
Weak transcription Enhancers Genic enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
3 |
rs565820694 |
chr2:112069852-112069853 |
Weak transcription Enhancers Genic enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
4 |
rs62161634 |
chr2:112069880-112069881 |
Weak transcription Enhancers Genic enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
5 |
rs71413065 |
chr2:112069923-112069924 |
Weak transcription Enhancers Genic enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
6 |
rs12614461 |
chr2:112069961-112069962 |
Weak transcription Enhancers Genic enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
7 |
rs547610121 |
chr2:112069988-112069989 |
Weak transcription Enhancers Genic enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
8 |
rs561215534 |
chr2:112070014-112070015 |
Enhancers Weak transcription Genic enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
9 |
rs150834373 |
chr2:112070018-112070019 |
Enhancers Weak transcription Genic enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
10 |
rs557981854 |
chr2:112070024-112070025 |
Enhancers Weak transcription Genic enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
11 |
rs201932769 |
chr2:112070038-112070039 |
Enhancers Weak transcription Genic enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
12 |
rs550107453 |
chr2:112070050-112070051 |
Enhancers Weak transcription Genic enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
13 |
rs569953410 |
chr2:112070051-112070052 |
Enhancers Weak transcription Genic enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
14 |
rs539069119 |
chr2:112070080-112070081 |
Enhancers Weak transcription Genic enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
15 |
rs375472759 |
chr2:112070083-112070084 |
Enhancers Weak transcription Genic enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
16 |
rs368521592 |
chr2:112070093-112070094 |
Enhancers Weak transcription Genic enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
17 |
rs560272518 |
chr2:112070098-112070099 |
Enhancers Weak transcription Genic enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
18 |
rs552379627 |
chr2:112070105-112070106 |
Enhancers Weak transcription Genic enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
19 |
rs566213905 |
chr2:112070112-112070113 |
Enhancers Weak transcription Genic enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
20 |
rs72627498 |
chr2:112070126-112070127 |
Enhancers Weak transcription Genic enhancers
|
n/a
|
n/a
|
LD-proxies of rSNPOverlapped rCNV
|
n/a
|
21 |
rs537503633 |
chr2:112070144-112070145 |
Enhancers Weak transcription Genic enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
22 |
rs870672 |
chr2:112070149-112070150 |
Enhancers Weak transcription Genic enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
23 |
rs377621554 |
chr2:112070187-112070188 |
Enhancers Weak transcription Genic enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
24 |
rs557409869 |
chr2:112070207-112070208 |
Weak transcription Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
25 |
rs885212 |
chr2:112070210-112070211 |
Weak transcription Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
26 |
rs192384323 |
chr2:112070214-112070215 |
Weak transcription Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
27 |
rs183943352 |
chr2:112070225-112070226 |
Weak transcription Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
28 |
rs187708587 |
chr2:112070228-112070229 |
Weak transcription Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
29 |
rs59996630 |
chr2:112070253-112070254 |
Weak transcription Enhancers
|
n/a
|
n/a
|
LD-proxies of rSNPOverlapped rCNV
|
n/a
|
30 |
rs368931058 |
chr2:112070320-112070321 |
Weak transcription Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
31 |
rs201354076 |
chr2:112070326-112070327 |
Weak transcription Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
32 |
rs545021727 |
chr2:112070327-112070328 |
Weak transcription Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
33 |
rs558345316 |
chr2:112070332-112070333 |
Weak transcription Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
34 |
rs571827449 |
chr2:112070412-112070413 |
Weak transcription Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
35 |
rs541189990 |
chr2:112070532-112070533 |
Weak transcription Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
36 |
rs542630560 |
chr2:112070550-112070551 |
Weak transcription Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
37 |
rs58475388 |
chr2:112070553-112070554 |
Weak transcription Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
38 |
rs192326672 |
chr2:112070556-112070557 |
Weak transcription Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
39 |
rs151150304 |
chr2:112070570-112070571 |
Weak transcription Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
40 |
rs543755549 |
chr2:112070578-112070579 |
Weak transcription Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
41 |
rs184662208 |
chr2:112070588-112070589 |
Weak transcription Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
42 |
rs4399729 |
chr2:112070640-112070641 |
Enhancers Weak transcription
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
43 |
rs59912265 |
chr2:112070647-112070648 |
Enhancers Weak transcription
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
44 |
rs4268930 |
chr2:112070685-112070686 |
Enhancers Weak transcription
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
45 |
rs552569902 |
chr2:112070737-112070738 |
Enhancers Weak transcription
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
46 |
rs4643548 |
chr2:112070754-112070755 |
Enhancers Weak transcription
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
47 |
rs566150825 |
chr2:112070788-112070789 |
Enhancers Weak transcription
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
48 |
rs191882972 |
chr2:112070814-112070815 |
Weak transcription Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
49 |
rs373405464 |
chr2:112070815-112070816 |
Weak transcription Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
50 |
rs184437288 |
chr2:112070832-112070833 |
Weak transcription Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|